PublizoomCall for tenders Supplies
Antineoplastic and immunomodulating agents (Pärnu Hospital)
Notice published in Estonian. The AI analysis summarises it for you in your language.
Tenders due in 26 days — 19 November 2026 at 09:00
“I want this contract”: tracking, reminders and a bid file prepared by AI (eligibility, schedule, cover letter, technical proposal).
- Public buyer
- Sihtasutus Pärnu Haigla
Pärnu linn - Place of performance
- Pärnu linn
- Planned end of contract
- 1 December 2027
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 15 October 2026
- Notice language
- Estonian
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Riigihanke eesmärgiks on sõlmida raamlepingud, mille objektiks on SA-le Pärnu Haigla kasvajavastaste ja immunomoduleerivate ainete ostmine, mille tehniline kirjeldus ja eeldatavad kogused on esitatud HD lisas 1. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
37 lots
- Palivizumab
- Dakarbasiin
- Etoposiid
- Epirubitsiin
- Obinutuzumab
- Daratumumab
- Pertuzumab
- Trastuzumabemtansiin
- Trastuzumabderukstekaan
- Panitumumab
- Nivolumab
- Pembrolizumab
- Durvalumab
- Avelumab
- Atesolizumab
- Tsemiplimab
- Brentuksimabvedotiin
- Pertuzumab+trastuzumab
- Karfilsomib
- Tsütarabiin+daunorubitsiin
- Filgrastiim
- Pegfilgrastiim
- Abatatsept
- Golimumab
- Ustekinumab
- Sarilumab
- Guselkumab
- Risankizumab
- Mirikizumab
- Belimumab
- Vedolizumab
- Okrelizumab
- Ravulizumab
- Eptinezumab
- Omalizumab
- Faritsimab
- Idarutsizumab
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €321,904
- Median
- €415,814
- A quarter above
- €4,753,350
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- AKTSIASELTS MEDITSIINIGRUPP · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- TAMRO EESTI OÜ · 12 contracts won in 3 years
- MAGNUM MEDICAL OÜ · 11 contracts won in 3 years
- Apteegikaubanduse Hulgimüük OÜ · 3 contracts won in 3 years
- Roche Eesti Osaühing · 3 contracts won in 3 years
- osaühing KALVERTON · 3 contracts won in 3 years
- AS Oribalt Tallinn · 2 contracts won in 3 years
- Osaühing Zoovetvaru · 2 contracts won in 3 years
- UAB Elins · 1 contract won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| PCV ja HPV vaktsiini ostmine Tervisekassa · 23 October 2026 |
AS Oribalt Tallinn TAMRO EESTI OÜ |
€4,753,350 |
| Tseftolosaan+tasobaktaam ja gentamütsiin ostmine 2026 Tervisekassa · 22 October 2026 |
MAGNUM MEDICAL OÜ Apteegikaubanduse Hulgimüük OÜ |
€263,189 |
| 99-Mo/99m-Tc radionukliidgeneraator sihtasutus Põhja-Eesti Regionaalhaigla · 13 October 2026 |
UAB Elins | €580,000 |
| Humaanravimite delegeeritud varu (2026_II-7) AS Eesti Varude Keskus · 12 October 2026 |
MAGNUM MEDICAL OÜ TAMRO EESTI OÜ |
– |
| Haiglaravimid - september 2026 sihtasutus Põhja-Eesti Regionaalhaigla · 30 September 2026 |
TAMRO EESTI OÜ MAGNUM MEDICAL OÜ Roche Eesti Osaühing |
€415,814 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 714853-2026.